stocksAPLLTD
APLLTD

Alembic Pharmaceuticals Ltd.

803.10-13.8 (-1.69%)
25 Aug, 12:00 AM

Annual Reports and Financial Documents

Alembic Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

Corporate Announcements and Regulatory Filings

Alembic Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Newspaper Publication25 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find attached.
  2. Appointment of Company Secretary / Compliance Officer20 Aug 2026
    Appointment of Company Secretary and Compliance Officer
    Intimation regarding Appointment of Company Secretary of the Company.
  3. Newspaper Publication11 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find attached.
  4. Resignation of Company Secretary / Compliance Officer10 Aug 2026
    Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
    Please find attached.
  5. AGM6 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Please find attached herewith the Scrutinizer Report and Voting Results of the AGM held on 5th August, 2026.
  6. AGM5 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Please find attached Proceedings of AGM held on 5th August, 2026.
  7. Newspaper Publication5 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find attached herewith the Newspaper Advertisement.
  8. Analyst / Investor Meet4 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Please find attached audio recording of investor call.
  9. Press Release / Media Release (Revised)4 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
    Please find attached Revised Press Release on Unaudited Financial Results for the quarter ended 30th June, 2026.
  10. Press Release / Media Release4 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Please find attached Press Release on Unaudited Financial Results for the quarter ended 30th June, 2026.
  11. Outcome of Board Meeting4 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Please find enclosed herewith Outcome of Board Meeting.
  12. Analyst / Investor Meet27 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Please find attached herewith Intimation for Investors Call Scheduled to be held on 4th August, 2026.
  13. Board Meeting24 Jul 2026
    Board Meeting Intimation for Board Meeting To Consider Unaudited Financial Results For The Quarter Ended 30Th June, 2026.
    Alembic Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve Unaudited Financial ....
  14. Press Release / Media Release18 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Alembic Pharmaceuticals Limited''s Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets 100 mg and 150 mg
  15. General13 Jul 2026
    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Please find enclosed.
  16. Newspaper Publication11 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Please find enclosed herewith the copy of the Newspaper Publication published on 11th July, 2026.
  17. General10 Jul 2026
    Specimen Copy Of The Letter Sent To The Shareholders Under Regulation 36(1)(B) Of SEBI LODR
    Please find enclosed.
  18. Record Date10 Jul 2026
    Intimation Of Record Date For Payment Of Dividend On Equity Shares For The Financial Year Ended 31St March, 2026.
    Please find enclosed herewith the intimation of Record Date for payment of Dividend on Equity Shares for the Financial Year ended 31st March, 2026.
  19. Business Responsibility and Sustainability Reporting (BRSR)10 Jul 2026
    Business Responsibility and Sustainability Reporting (BRSR)
    Please find enclosed herewith a copy of the Business Responsibility and Sustainability Report of the Company including Reasonable Assurance Report for the Financial Year ended 31st March, 2026.
  20. Reg. 34 (1) Annual Report10 Jul 2026
    Reg. 34 (1) Annual Report.
    Please find enclosed herewith a copy of Annual Report of the Company for the Financial Year ended 31st March, 2026.

Frequently Asked Questions

Where can I download the annual report of Alembic Pharmaceuticals Ltd.?
Annual reports of Alembic Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Alembic Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Alembic Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Alembic Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Alembic Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Alembic Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Alembic Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Alembic Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Alembic Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Alembic Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Alembic Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Alembic Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Alembic Pharmaceuticals Ltd. is INE901L01018. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Alembic Pharmaceuticals Ltd. listed?
Alembic Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is APLLTD and the BSE code is -.
Where can I find the shareholding pattern of Alembic Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Alembic Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Alembic Pharmaceuticals Ltd. on Sharpely?
Share price data for Alembic Pharmaceuticals Ltd. is updated as of 25 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.